CA2744756C - Monocarbams and their use as antibacterial agent - Google Patents

Monocarbams and their use as antibacterial agent Download PDF

Info

Publication number
CA2744756C
CA2744756C CA2744756A CA2744756A CA2744756C CA 2744756 C CA2744756 C CA 2744756C CA 2744756 A CA2744756 A CA 2744756A CA 2744756 A CA2744756 A CA 2744756A CA 2744756 C CA2744756 C CA 2744756C
Authority
CA
Canada
Prior art keywords
compound
oxo
mmol
compounds
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2744756A
Other languages
English (en)
French (fr)
Other versions
CA2744756A1 (en
Inventor
Steven Joseph Brickner
Mark Edward Flanagan
Manjinder Singh Lall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of CA2744756A1 publication Critical patent/CA2744756A1/en
Application granted granted Critical
Publication of CA2744756C publication Critical patent/CA2744756C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CA2744756A 2008-12-19 2009-12-07 Monocarbams and their use as antibacterial agent Expired - Fee Related CA2744756C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13915908P 2008-12-19 2008-12-19
US61/139,159 2008-12-19
PCT/IB2009/055544 WO2010070523A1 (en) 2008-12-19 2009-12-07 Monocarbams

Publications (2)

Publication Number Publication Date
CA2744756A1 CA2744756A1 (en) 2010-06-24
CA2744756C true CA2744756C (en) 2013-05-28

Family

ID=41727494

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2744756A Expired - Fee Related CA2744756C (en) 2008-12-19 2009-12-07 Monocarbams and their use as antibacterial agent

Country Status (15)

Country Link
US (2) US8252782B2 (enExample)
EP (1) EP2379546A1 (enExample)
JP (1) JP2012512863A (enExample)
KR (1) KR20110086742A (enExample)
CN (1) CN102325769A (enExample)
AR (1) AR074801A1 (enExample)
AU (1) AU2009329169B2 (enExample)
CA (1) CA2744756C (enExample)
IL (1) IL213216A0 (enExample)
MX (1) MX2011006541A (enExample)
PA (1) PA8855001A1 (enExample)
SG (1) SG171781A1 (enExample)
TW (1) TW201026696A (enExample)
UY (1) UY32336A (enExample)
WO (1) WO2010070523A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2744756C (en) * 2008-12-19 2013-05-28 Pfizer Inc. Monocarbams and their use as antibacterial agent
JP5777725B2 (ja) 2010-11-29 2015-09-09 ファイザー・インク モノバクタム
UY34585A (es) * 2012-01-24 2013-09-02 Aicuris Gmbh & Co Kg Compuestos b-lactámicos sustituidos con amidina, su preparación y uso
AU2016327264B2 (en) 2015-09-23 2019-06-27 Novartis Ag Salts and solid forms of monobactam antibiotic
CN105481812B (zh) * 2015-11-30 2020-04-21 重庆天奕恒化科技有限公司 一种5-苄氧基-4-氧代-4h-吡喃-2-羧酸的制备方法
CN110312715A (zh) 2016-12-21 2019-10-08 艾库里斯有限及两合公司 用于抗生素耐药性细菌菌株感染的使用脒取代的β-内酰胺化合物和β-内酰胺酶抑制剂的组合疗法
ES2912656T3 (es) 2017-08-02 2022-05-26 Novartis Ag Proceso para preparar ácido 1-(((Z)-(1-(2-aminotiazol-4-il)-2-oxo-2-(((3S,4R)-2-oxo-4-((2-oxooxazolidin-3-il)metil)-1-sulfoacetidin-3-il)amino)etiliden)amino)oxi)ciclopropano carboxílico
US11034648B2 (en) 2017-08-23 2021-06-15 Helmholtz-Zentrum Für Cystobactamide derivatives
WO2019045085A1 (ja) 2017-08-31 2019-03-07 北興化学工業株式会社 １－（ｎ，ｎ－ジ置換カルバモイル）４－（置換スルホニル）トリアゾリン－５－オン誘導体、４－（ｎ，ｎ－ジ置換カルバモイル）１－（置換スルホニル）トリアゾリン－５－オン誘導体、およびそれらを有効成分として含有する除草剤
EP3747883A4 (en) 2018-01-29 2020-12-16 Medshine Discovery Inc. MONOCYCLIC B-LACTAM COMPOUND FOR TREATING BACTERIAL INFECTION
WO2020125670A1 (zh) 2018-12-18 2020-06-25 南京明德新药研发有限公司 单环β-内酰胺化合物在制药中的应用
US12491180B2 (en) 2019-12-19 2025-12-09 Shenzhen Optimum Biological Technology Co., Ltd Application of compound in treating pneumonia
JP2025513455A (ja) 2022-04-22 2025-04-24 バーテックス ファーマシューティカルズ インコーポレイテッド 疼痛の治療のためのヘテロアリール化合物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ199981A (en) 1981-04-09 1985-08-16 Squibb & Sons Inc 2-oxo-1-(((substituted sulphonyl)amino)carbonyl)azetidines
US4587047A (en) * 1981-04-09 1986-05-06 E. R. Squibb & Sons, Inc. 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines
US5006650A (en) * 1987-02-11 1991-04-09 The Upjohn Company Novel N-1 substituted beta-lactams as antibiotics
DE3864257D1 (de) 1987-02-11 1991-09-19 Upjohn Co Neue n-1 substituierte beta-lactame als antibiotika.
US5001235A (en) * 1987-02-27 1991-03-19 The Upjohn Company Antibiotic beta-lactams containing a pyridone carboxylic acid or acid derivative
CA1317298C (en) * 1987-03-03 1993-05-04 Upjohn Company (The) Antibiotic sulfonylaminocarbonyl activated .beta.-lactams
US4762922A (en) * 1987-07-01 1988-08-09 Squibb Corporation 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines
US5015737A (en) * 1987-07-22 1991-05-14 The Upjohn Company Therapeutically useful beta-lactams
US4777252A (en) * 1987-08-13 1988-10-11 E. R. Squibb & Sons, Inc. 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines
US4889930A (en) 1987-12-21 1989-12-26 E. R. Squibb & Sons, Inc. Process for making 2-oxo-1-((substituted sulfonyl)amino)carbonzyl)azetidines and intermediates used therein
JPH01305081A (ja) 1988-04-04 1989-12-08 E R Squibb & Sons Inc ３―アシルアミノ―１―［［［（置換スルホニル）アミノ〕カルボニル〕アミノ〕―２―アゼチジノン類
EP0344707A3 (en) 1988-06-02 1990-04-18 E.R. Squibb & Sons, Inc. 2-Oxo-1-[[(substituted sulfonyl)-amino]carbonyl]-azetidine derivatives
US4959470A (en) * 1988-08-17 1990-09-25 E. R. Squibb & Sons, Inc. 2-oxo-[[(substituted sulfonyl)-amino]carbonyl]-azetidines
EP0436568A1 (en) 1988-09-27 1991-07-17 The Upjohn Company Dihydroxyaryl 4-substituted monocarbams as antibiotics
CA2210787A1 (en) 1997-07-17 1999-01-17 William R. Collier Self-contained work station
BRPI0809147A2 (pt) 2007-03-23 2014-08-26 Basilea Pharmaceutica Ag Medicamentos combinados para tratamento de infecções bacterianas
CA2744756C (en) * 2008-12-19 2013-05-28 Pfizer Inc. Monocarbams and their use as antibacterial agent

Also Published As

Publication number Publication date
CA2744756A1 (en) 2010-06-24
JP2012512863A (ja) 2012-06-07
TW201026696A (en) 2010-07-16
AU2009329169A1 (en) 2010-06-24
EP2379546A1 (en) 2011-10-26
US20100160281A1 (en) 2010-06-24
CN102325769A (zh) 2012-01-18
IL213216A0 (en) 2011-07-31
SG171781A1 (en) 2011-07-28
US20120289455A1 (en) 2012-11-15
WO2010070523A1 (en) 2010-06-24
KR20110086742A (ko) 2011-07-29
PA8855001A1 (es) 2010-07-27
US8252782B2 (en) 2012-08-28
MX2011006541A (es) 2011-07-20
AU2009329169B2 (en) 2012-06-28
UY32336A (es) 2010-07-30
AR074801A1 (es) 2011-02-16
US8324198B1 (en) 2012-12-04

Similar Documents

Publication Publication Date Title
AU2009329169B2 (en) Monocarbams
AU2020256814B2 (en) Methods and compositions for targeted protein degradation
AU2012238374B2 (en) Isoxazole derivatives useful as antibacterial agents
CN106255679B (zh) 用作nav通道抑制剂的杂环化合物及其用途
CA3036557A1 (en) Beta-lactamase inhibitor compounds
KR20130140164A (ko) 항박테리아제로서 유용한 이미다졸, 피라졸 및 트라이아졸 유도체
CA3195464A1 (en) Methods and compositions for targeted protein degradation
JP4064462B2 (ja) セフェム化合物及び該化合物を含有する医薬
MX2011008308A (es) Derivados de azaspiranil-alquilcarbamatos de heterociclos de 5 eslabones, su preparacion y su aplicacion en terapeutica.
US11208387B2 (en) Macrocyclic broad spectrum antibiotics
JP7598594B2 (ja) オキソ置換化合物
CA2691485A1 (en) Chemical compounds
TW202340182A (zh) 做為ｒｉｐｋ１抑制劑之異㗁唑啶及其用途
EP1618106B1 (en) Carbacephem beta-lactam antibiotics
WO2018045313A1 (en) Substituted urea depsipeptide analogs as activators of the clpp endopeptidase
US20180282331A1 (en) 7-Oxo -6-(sulfooxy)- 1,6-diazabicyclo [3.2.1] octane containing compounds and their use in treatment of bacterial infections (changed by PCT to: 7-OXO -6-(SULFOOXY)- 1,6-DIAZABICYCLO [3.2.1] OCTANE CONTAINING COMPOUNDS AND THEIR USE IN TREATMENT OF BACTERIAL INFECTIONS
WO2009106967A1 (fr) Nouveaux derives 7-substitues de 3-carboxy-oxadiazino-quinolones, leur preparation et leur application comme anti-bacteriens
PT1896452E (pt) Compostos de n-formil hidroxilamina
JP7550421B2 (ja) オキソ置換化合物からなる医薬
AU2021384582A9 (en) Novel compound, preparation method thereof, and antibiotic composition comprising same
GB2602096A (en) Compounds
WO2021165927A1 (en) 2-cyanopyrroldines, -piperidines or -dazepines as hyperglycemic agents
HK1161238A (en) Monocarbams
WO2000034274A1 (en) Cyclohexylpiperidine derivatives
HK40076912A (en) Macrocyclic broad spectrum antibiotics

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20151207